Fig. 2From: Monitoring response to anti-angiogenic mTOR inhibitor therapy in vivo using 111In-bevacizumabDistribution of 111In-bevacizumab after 5 days in mice bearing different tumour xenografts. Black = FaDu, hatched = LS 174T, white = 786-O. Data are presented as mean ± SEM, n = minimum of 4 mice/groupBack to article page